State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF vs Tilray Brands Inc — how do they compare? State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.9, while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| SJNK | TLRY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $25.63 | $21.00 |
52-Week Low | $24.75 | $4.23 |
Market Cap | — | $524.07M |
Enterprise Value | — | $621.22M |
Signals from Pluang's Aura AI — not financial advice
SJNK trades at $24.92 with no change over the past 24 hours, reflecting stability amid a bearish technical signal from moving averages. The ETF maintains a neutral stance in oscillators, with RSI levels indicating neither overbought nor oversold conditions. Recent corporate actions include scheduled dividend payments, with H2-26 set at $0.15 per share. Institutional activity shows Balefire LLC reduced its stake by 74.7% in the latest quarter, as per SEC filings dated 2026-07-21.
The outlook for SJNK is cautious due to bearish technical indicators and negative sentiment from analysts, who rate it SELL citing exhausted tailwinds from falling yields. Risks include high sensitivity to interest rate changes and credit spread volatility. Investment opportunity lies in its high-yield bond focus, but current conditions suggest limited near-term upside amid macroeconomic uncertainties.
TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.
The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.
Trailing returns across standard periods
Latest headlines on both assets
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →